Database: EBM Reviews - Cochrane Database of Systematic Reviews <2nd Quarter 2008>
Search Strategy:
1carbamazepine.mp. or exp Carbamazepine/(95)
2tegretol.mp. (4)
3divalproex.mp. or exp Valproic acid/(17)
4valproic acid.mp. (29)
5depakote.mp. (3)
6ethotoin.mp. (1)
7peganone.mp. (0)
8gabapentin.mp. (54)
9neurontin.mp. (0)
10lamotrigine.mp. (42)
11lamictal.mp. (2)
12levetiracetam.mp. (12)
13keppra.mp. (0)
14oxcarbazepine.mp. (22)
15trileptal.mp. (4)
16phenytoin.mp. or exp Phenytoin/(66)
17dilantin.mp. (1)
18pregabalin.mp. (16)
19lyrica.mp. (1)
20tiagabine.mp. (20)
21gabitril.mp. (2)
22topiramate.mp. (29)
23depakene.mp. (4)
24depacon.mp. (2)
25zonisamide.mp. (17)
26zonegran.mp. (0)
271 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 (154)
28fibromyalgia.mp. or exp Fibromyalgia/(24)
29fibrositis.mp. (1)
3028 or 29 (24)
3127 and 30 (4)
32limit 31 to yr="2005 – 2008" (4)
33from 32 keep 1–4 (4)

From: Appendix C, Search strategy and update history

Cover of Drug Class Review: Antiepileptic Drugs for Indications Other Than Epilepsy
Drug Class Review: Antiepileptic Drugs for Indications Other Than Epilepsy: Final Report Update 2 [Internet].
McDonagh M, Peterson K, Lee N, et al.
Portland (OR): Oregon Health & Science University; 2008 Oct.
Copyright © 2008, Oregon Health & Science University, Portland, Oregon.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.